Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 54.84

+0.2%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: rkrw who wrote (17396)	7/26/2005 7:26:18 PM
From: zeta1961	Read Replies (1) of 52153

hmm..this past spring, Warburg Pincus established a mid40% position in ALTH...they failed ODAC '04 in metastasis to brain from breast cancer with their radiation sensitizer, RSR-13.. rkrw, long term ALTH YMBers have cited your example..their molecule is currently in a P3 trial with projected accrual by EOY..fwiw..no position Hard for me to believe these deals were done for lack of finance acumen..

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next